Organigram Global Inc. (NASDAQ:OGI – Get Free Report) saw some unusual options trading activity on Tuesday. Investors acquired 3,000 call options on the company. This represents an increase of approximately 1,041% compared to the average volume of 263 call options.
Hedge Funds Weigh In On Organigram Global
An institutional investor recently raised its position in Organigram Global stock. Lazard Asset Management LLC grew its position in shares of Organigram Global Inc. (NASDAQ:OGI – Free Report) by 108.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 346,796 shares of the company’s stock after purchasing an additional 180,327 shares during the period. Lazard Asset Management LLC owned approximately 0.25% of Organigram Global worth $465,000 at the end of the most recent reporting period. 34.63% of the stock is currently owned by institutional investors.
Organigram Global Stock Performance
Shares of Organigram Global stock traded down $0.00 on Tuesday, hitting $0.72. 49,463 shares of the company’s stock were exchanged, compared to its average volume of 732,786. The company has a 50-day simple moving average of $0.97 and a 200-day simple moving average of $1.16. The stock has a market capitalization of $102.02 million, a PE ratio of 1.57 and a beta of 1.55. Organigram Global has a 1 year low of $0.71 and a 1 year high of $2.24. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.07 and a current ratio of 2.61.
Analyst Upgrades and Downgrades
A number of research analysts have recently commented on the stock. Weiss Ratings cut shares of Organigram Global from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday. Wall Street Zen upgraded Organigram Global from a “sell” rating to a “hold” rating in a research report on Saturday, August 15th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold”.
About Organigram Global
Organigram Global Inc. is a Canadian cannabis company that cultivates, processes and sells cannabis and cannabinoid products. Its offerings include dried flower, pre-rolls, edibles, vape products, concentrates and cannabis-infused beverages, sold under brands such as Edison, SHRED, Big Bag O’ Buds and BOXHOT. The company traces its roots to Organigram, a licensed cannabis producer established in New Brunswick. It expanded its portfolio and manufacturing capabilities through acquisitions, including the 2024 purchase of Canadian cannabis company Motif Labs.
Further Reading
- Five stocks we like better than Organigram Global
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake
- Tyson Foods’ 10% Surge Puts a Breakout in Sight, But Wall Street Remains Cautious
- Microsoft’s Outage Barely Moved Its Stock, But a Bigger Risk May Be Building
Receive News & Ratings for Organigram Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram Global and related companies with MarketBeat.com's FREE daily email newsletter.
